HYBRID EVENT: You can participate in person at London, UK or Virtually from your home or work.

5th Edition of Euro-Global Conference on Biotechnology and Bioengineering

September 18-20 | Hybrid Event

September 18-20, 2025 | London, UK

Drug Metabolism

Drug Metabolism

Drug Metabolism refers to the biochemical processes by which a drug is transformed within the body. This intricate process primarily occurs in the liver and involves a series of enzymatic reactions aimed at converting drugs into metabolites that can be easily excreted from the body. The primary goal of drug metabolism is to facilitate the elimination of drugs from the system while often making them more water-soluble for efficient excretion through urine or bile. The process of drug metabolism can be broadly categorized into two phases: Phase I and Phase II metabolism. Phase I metabolism typically involves oxidation, reduction, or hydrolysis reactions, mediated mainly by enzymes such as cytochrome P450 (CYP) enzymes. These reactions often introduce or expose functional groups on the drug molecule, rendering it more amenable to subsequent modification. Following Phase I metabolism, Phase II reactions involve the conjugation of the drug or its metabolites with endogenous molecules such as glucuronic acid, sulfate, or amino acids. This conjugation process enhances the water solubility of the drug metabolites, facilitating their elimination via urine or bile. Enzymes such as UDP-glucuronosyltransferases (UGTs) and sulfotransferases are pivotal in Phase II metabolism. The interplay between Phase I and Phase II metabolism ensures efficient drug elimination while often producing metabolites with altered pharmacological activity. However, it's essential to note that drug metabolism can vary significantly among individuals due to genetic factors, environmental influences, and concurrent medications.

Committee Members
Speaker at Biotechnology and Bioengineering 2025 - Thomas J Webster

Thomas J Webster

Interstellar Therapeutics, United States
Speaker at Biotechnology and Bioengineering 2025 - Steve Busby

Steve Busby

University of Birmingham, United Kingdom
Speaker at Biotechnology and Bioengineering 2025 - Murray Moo Young

Murray Moo Young

University of Waterloo, Canada
ECBB 2025 Speakers
Speaker at Biotechnology and Bioengineering 2025 - Julia Sidorova

Julia Sidorova

Centro de Investigación Biomédica En Red Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain
Speaker at Biotechnology and Bioengineering 2025 - Luis Jesus Villarreal Gomez

Luis Jesus Villarreal Gomez

Universidad Autonoma de Baja California, Mexico
Speaker at Biotechnology and Bioengineering 2025 - Assad Al Ammar

Assad Al Ammar

Specialty Enzymes and Probiotics, United States
Speaker at Biotechnology and Bioengineering 2025 - Tina Moller Tagmose

Tina Moller Tagmose

Novo Nordisk A/S, Denmark

Submit your abstract Today

Watsapp
a